09:01 AM EST - Lexston Life Sciences Corp. : Announced that the company’s wholly owned subsidiary, Egret Bioscience Ltd. has recently received funding from the Canadian government for their project on Cannabis transformation to develop new breeding techniques using CRISPR-Cas9 technology. The project, entitled “Screening of Egret’s hemp genotypes for proof of concept tissue culture and transformation method validation“ was initiated by the National Research Council of Canada (NRC) in July 2021 through their Industrial Research Assistance Program (NRC-IRAP). The Government contribution to the research totals over CAD$55,000. The goal of this year-long project is to develop new high essential oil hemp genotypes by manipulating the Cannabis sativa L. genome with the CRISPR gene editing system at targets identified by Egret scientists. Lexston Life Sciences Corp.
shares C.LEXT are trading unchanged at $0.12.
